For research use only. Not for therapeutic Use.
Robenacoxib is a nonsteroidal anti-inflammatory and analgesic agent. Robenacoxib is a selective COX-2 inhibitor[1][2].
| Catalog Number | R013800 |
| CAS Number | 220991-32-2 |
| Synonyms | 2-[5-ethyl-2-(2,3,5,6-tetrafluoroanilino)phenyl]acetic acid |
| Molecular Formula | C16H13F4NO2 |
| Purity | ≥95% |
| InChI | InChI=1S/C16H13F4NO2/c1-2-8-3-4-12(9(5-8)6-13(22)23)21-16-14(19)10(17)7-11(18)15(16)20/h3-5,7,21H,2,6H2,1H3,(H,22,23) |
| InChIKey | ZEXGDYFACFXQPF-UHFFFAOYSA-N |
| SMILES | CCC1=CC(=C(C=C1)NC2=C(C(=CC(=C2F)F)F)F)CC(=O)O |
| Reference | [1]. Kongara K, et al. Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy. Vet Med (Auckl). 2018 Aug 15;9:53-61. [2]. Schmid VB, et al. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. J Vet Pharmacol Ther. 2010 Apr;33(2):118-31. |
